StockNews.com lowered shares of Macerich (NYSE:MAC – Free Report) from a hold rating to a sell rating in a research report report published on Thursday morning.
Several other equities research analysts have also recently weighed in on MAC. Bank of America upped their target price on Macerich from $17.00 to $19.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Evercore ISI upped their price objective on Macerich from $15.00 to $16.00 and gave the stock an “in-line” rating in a research note on Wednesday, August 28th. Compass Point upped their price objective on Macerich from $20.00 to $23.00 and gave the stock a “buy” rating in a research note on Thursday. Piper Sandler upped their price objective on Macerich from $11.00 to $14.00 and gave the stock an “underweight” rating in a research note on Tuesday, September 3rd. Finally, The Goldman Sachs Group upped their target price on Macerich from $13.00 to $14.60 and gave the company a “sell” rating in a research report on Thursday, September 19th. Five equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $16.40.
Check Out Our Latest Stock Analysis on Macerich
Macerich Trading Up 1.1 %
Macerich Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Tuesday, November 12th will be given a dividend of $0.17 per share. The ex-dividend date is Tuesday, November 12th. This represents a $0.68 dividend on an annualized basis and a yield of 3.48%. Macerich’s dividend payout ratio is currently -206.05%.
Hedge Funds Weigh In On Macerich
A number of hedge funds have recently bought and sold shares of MAC. Russell Investments Group Ltd. boosted its position in Macerich by 1,845.1% during the first quarter. Russell Investments Group Ltd. now owns 1,168,864 shares of the real estate investment trust’s stock worth $20,133,000 after purchasing an additional 1,108,770 shares in the last quarter. Smead Capital Management Inc. lifted its position in shares of Macerich by 3.5% in the third quarter. Smead Capital Management Inc. now owns 20,433,449 shares of the real estate investment trust’s stock valued at $372,706,000 after acquiring an additional 688,790 shares in the last quarter. Sei Investments Co. purchased a new position in shares of Macerich in the second quarter valued at approximately $10,625,000. Millennium Management LLC lifted its position in shares of Macerich by 153.0% in the second quarter. Millennium Management LLC now owns 791,903 shares of the real estate investment trust’s stock valued at $12,227,000 after acquiring an additional 478,930 shares in the last quarter. Finally, Candriam S.C.A. lifted its position in shares of Macerich by 138.2% in the second quarter. Candriam S.C.A. now owns 528,252 shares of the real estate investment trust’s stock valued at $8,156,000 after acquiring an additional 306,509 shares in the last quarter. Hedge funds and other institutional investors own 87.38% of the company’s stock.
Macerich Company Profile
Macerich is a fully integrated, self-managed and self-administered real estate investment trust (REIT). As a leading owner, operator and developer of high-quality retail real estate in densely populated and attractive U.S. markets, Macerich’s portfolio is concentrated in California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, DC corridor.
Further Reading
- Five stocks we like better than Macerich
- Market Cap Calculator: How to Calculate Market Cap
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- What is a SEC Filing?
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- How to Start Investing in Real Estate
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for Macerich Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Macerich and related companies with MarketBeat.com's FREE daily email newsletter.